- Evidence from controlled settings clearly point to face masks providing disease control benefits because they prevent the disease particles entering the air and prevent infected persons from spreading the disease
- However, in the real-world, the evidence isn’t as sure; some trials either report non-significant results (erring towards more harmful) or outright more harmful
- This is believed to be a result of using ineffectual or poor-quality masks (e.g. cloth), and people exhibiting risk compensation behaviours (i.e. acting less carefully as they believe the mask will make up for their actions)
Click here to learn more
SVMPharma is an innovative strategic consultancy, specialising in Real World Evidence (RWE) for the pharmaceutical industry. SVMPharma generates RWE within UK and Europe through bespoke online Real World Treatment Evaluators, leading to successful health technology appraisal (HTA) submissions. Clinical trial programmes do not reflect real-world clinical practice and outcomes, RWE supplements and enhances clinical datasets. SVMPharma’s specialist teams focus on delivering the outcomes that matter to your brand.